date:Jul 21, 2012
Its own Hi-Maize 260 product has achieved an Article 13 claim for blood sugar management support and ConAgras Sustagrain wholegrain barley, distributed across Europe by National Starch Food Innovation, has been given Article 13 claims relating to digestive health, cholesterol levels and also blood sugar management.
Hi-Maize now holds the claim replacing digestible starches with resistant starch contributes to a reduction in the blood glucose rise after a meal.
Sustagrain can now claim that i